Schedule 13G ownership disclosure
C4 Therapeutics Inc
Security class unavailable · CUSIP: 12529R107
Event date: 2022-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-22-001528
- Form type
- SC 13G
- Filer
- ArrowMark Colorado Holdings LLC
- CIK
- CIK 1483859
- Filed
- Jun 10, 2022
- Reporting period
- May 31, 2022
- Description
- Schedule 13G beneficial ownership